— San Diego-based Batu Biologics, an oncology company dedicated to the development of its clinical stage tumor-angiogenesis targeting immunotherapy, announced the successful closure of a 506(c) equity crowdfunding offering bringing in $1...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • NEW: San Diego 500 — influential business leaders you need to know
Yours for only $129